Elbona, 200 mg/ml 2 ml 6 pcs

Pharmaceutical group:

Tissue regeneration stimulator.

Pharmaceutical action:

Elbona is a drug that stimulates the process of cartilage tissue repair.

Glucosamine sulfate has anti-inflammatory and analgesic effect, compensates endogenous glucosamine deficiency, stimulates the synthesis of proteoglycans and hyaluronic acid synovial fluid; promotes sulfur fixation during synthesis of chondroitinic acid, inhibits the development of degenerative processes in joints and restores their function.

Glucosamine helps prevent the destruction of cartilage, stimulates the restoration of cartilage tissue. It improves mobility of joints and reduces the need for NSAIDs.

Indications

Primary and secondary osteoarthritis, spondyloarthrosis.

Pharmacological effect

Pharmaceutical group:

tissue regeneration stimulator.

Pharmaceutical action:

Elbona is a drug that stimulates the repair process of cartilage tissue.

Glucosamine sulfate has anti-inflammatory and analgesic effects, replenishes endogenous glucosamine deficiency, stimulates the synthesis of proteoglycans and hyaluronic acid in synovial fluid; promotes the fixation of sulfur in the process of chondroitinsulfuric acid synthesis, inhibits the development of degenerative processes in joints, and restores their function.

Glucosamine helps prevent cartilage destruction and stimulates the restoration of cartilage tissue. Improves joint mobility, reduces the need for NSAIDs.

Special instructions

If you are intolerant to seafood (shrimp, shellfish), the likelihood of developing allergic reactions increases with the use of Elbona.

Active ingredient

Glucosamine

Composition

Solution A:

2 ml of solution for intramuscular administration contains:

active ingredient:

glucosamine sulfate sodium chloride 502.5 mg (which corresponds to the content: glucosamine sulfate 400 mg, sodium chloride 102.5 mg).

excipients:

trometamol to pH 2.0-3.0,

lidocaine hydrochloride 10 mg,

water for injections up to 2 ml.

Solution B (solvent):

1 ml of solution contains:

diethanolamine 24 mg,

water for injections up to 1 ml.

Contraindications

Individual hypersensitivity to glucosamine, lidocaine hydrochloride and other components of Elbona. Phenylketonuria.
Due to the presence of lidocaine in the drug, it is contraindicated in:

Cardiac conduction disorders.
Acute heart failure.
History of epileptiform seizures.
Severe dysfunction of the liver and kidneys.
During pregnancy.
During lactation.
In children up to 12 years of age.

With caution:

Chronic heart failure.
Arterial hypotension.
Bronchial asthma.
Diabetes mellitus.
Seafood intolerance (shrimp, shellfish) – the likelihood of developing allergic reactions to the drug increases.

Side Effects

The drug is well tolerated.

In some cases, possible: flatulence, diarrhea, constipation, allergic reactions (urticaria, itching).

Due to the content of lidocaine in the drug, the following are possible: nausea, vomiting, drowsiness, diplopia, headache, dizziness, numbness of the tongue and oral mucosa, tremor, euphoria, disorientation, cardiac conduction disturbances, anaphylactic reactions.

Interaction

Compatible with NSAIDs, paracetamol and GCS. Cimetidine and propranolol reduce the hepatic clearance of lidocaine (decreased metabolism due to inhibition of microsomal oxidation and decreased hepatic blood flow) and increase the risk of toxic effects.

When prescribed with ajmaline, phenytoin, verapamil, quinidine, amiodarone, the negative inotropic effect may be enhanced. Co-administration with beta-blockers increases the risk of bradycardia. Cardiac glycosides weaken the cardiotonic effect.

Curare-like drugs enhance muscle relaxation. Procainamide, when used simultaneously with lidocaine, increases the risk of developing central nervous system excitation and hallucinations.

When hypnotics and sedatives are prescribed simultaneously, their inhibitory effect on the central nervous system may be enhanced.

With intravenous administration of hexobarbital or sodium thiopental against the background of the action of lidocaine, respiratory depression is possible. Potentiates the effects of MAO inhibitors.

When used simultaneously with polymyxin B, the inhibitory effect on neuromuscular transmission may be enhanced, so in this case it is necessary to monitor the patient’s respiratory function. The effectiveness of hypoglycemic drugs, doxorubicin, teniposide, and etoposide may decrease.

Storage conditions

Store in a dry place, protected from light, at a temperature not exceeding 25°C.

Shelf life

2 years.

Manufacturer

Ellara LLC, Russia